Goeltz II Robert C.
Insider CIK 1653881 · UBX Chief Financial Officer · CTMX Chief Financial Officer · RCUS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences, Inc. | S Sale | 2026-05-11 | 2026-05-12 | 7,763 | $25.63 | $199.0K | 84,161 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2026-01-23 | 2026-01-26 | 96,000 | — | $0 | 96,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2026-01-23 | 2026-01-26 | 24,000 | — | $0 | 91,924 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-12-31 | 2026-01-02 | 6,552 | $23.38 | $153.2K | 67,924 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-12-17 | 2025-12-18 | 5,960 | $22.16 | $132.1K | 74,476 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-12-16 | 2025-12-18 | 6,702 | $21.88 | $146.6K | 80,436 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-11-26 | 2025-11-26 | 5,000 | $25.00 | $125.0K | 87,138 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-10-28 | 2025-10-29 | 5,000 | $20.00 | $100.0K | 92,138 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2025-01-23 | 2025-01-27 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2025-01-23 | 2025-01-27 | 37,000 | — | $0 | 97,138 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2024-12-31 | 2025-01-03 | 3,594 | $15.00 | $53.9K | 60,138 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | F Tax w/h | 2024-12-15 | 2024-12-17 | 10,099 | $16.08 | $162.4K | 63,732 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2024-01-23 | 2024-01-25 | 86,600 | — | $0 | 86,600 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2024-01-23 | 2024-01-25 | 21,300 | — | $0 | 73,131 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2024-01-23 | 2024-02-23 | 22,000 | — | $0 | 73,831 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 2,004 | $20.00 | $40.1K | 51,831 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | D To issuer | 2023-12-19 | 2023-12-20 | 2,808 | $18.09 | $50.8K | 53,835 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | D To issuer | 2023-12-18 | 2023-12-20 | 2,749 | $17.74 | $48.8K | 56,643 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2023-06-07 | 2023-06-09 | 4,049 | $20.04 | $81.1K | 59,392 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2023-01-23 | 2023-01-25 | 138,200 | — | $0 | 138,200 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2023-01-23 | 2023-01-25 | 34,000 | — | $0 | 63,441 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2022-12-16 | 2022-12-16 | 2,066 | $30.66 | $63.3K | 11,953 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2022-12-16 | 2022-12-16 | 387 | $31.23 | $12.1K | 11,566 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2022-03-08 | 2022-03-10 | 62,500 | — | $0 | 62,500 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2022-03-08 | 2022-03-10 | 15,500 | — | $0 | 22,519 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-17 | 2021-12-20 | 224 | $41.42 | $9.3K | 7,019 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-17 | 2021-12-20 | 171 | $40.57 | $6.9K | 7,243 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-17 | 2021-12-20 | 88 | $39.67 | $3.5K | 7,414 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-17 | 2021-12-20 | 138 | $38.79 | $5.4K | 7,502 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-16 | 2021-12-20 | 131 | $40.46 | $5.3K | 7,640 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-16 | 2021-12-20 | 354 | $39.59 | $14.0K | 7,771 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2021-01-19 | 2021-01-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2021-01-19 | 2021-01-20 | 12,500 | — | $0 | 17,500 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2020-09-09 | 2020-09-09 | 5,000 | $21.57 | $107.8K | 5,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2020-08-03 | 2020-08-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| UBX Unity Biotechnology, Inc. | F Tax w/h | 2020-06-22 | 2020-06-24 | 2,483 | $9.67 | $24.0K | 161,027 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2020-03-30 | 2020-04-01 | 118,188 | — | $0 | 118,188 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award | 2020-03-30 | 2020-04-01 | 29,106 | — | $0 | 163,510 | SEC↗ |
| UBX Unity Biotechnology, Inc. | M Exercise deriv | 2020-02-24 | 2020-02-26 | 10,000 | — | $0 | 110,620 | SEC↗ |
| UBX Unity Biotechnology, Inc. | M Exercise | 2020-02-24 | 2020-02-26 | 10,000 | $3.43 | $34.3K | 134,404 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2019-09-19 | 2019-09-23 | 28,814 | — | $0 | 28,814 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2019-06-20 | 2019-06-24 | 116,850 | — | $0 | 116,850 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award | 2019-06-20 | 2019-06-24 | 21,075 | — | $0 | 124,404 | SEC↗ |
| UBX Unity Biotechnology, Inc. | M Exercise deriv | 2018-10-10 | 2018-10-12 | 5,000 | — | $0 | 120,620 | SEC↗ |
| UBX Unity Biotechnology, Inc. | M Exercise | 2018-10-10 | 2018-10-12 | 5,000 | $3.43 | $17.1K | 101,348 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 1,630 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 1,630 | — | $0 | 96,348 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2018-05-02 | 2018-05-04 | 30,508 | — | $0 | 30,508 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2017-05-12 | 2017-05-16 | 9,980 | — | $0 | 204,678 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2017-05-12 | 2017-05-16 | 9,987 | — | $0 | 85,891 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2017-05-12 | 2017-05-16 | 9,987 | $6.61 | $66.0K | 32,756 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2017-05-12 | 2017-05-16 | 9,980 | $4.47 | $44.6K | 22,769 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2017-04-10 | 2017-04-11 | 3,000 | — | $0 | 214,658 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2017-04-10 | 2017-04-11 | 3,000 | $4.47 | $13.4K | 12,789 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2017-03-20 | 2017-03-21 | 21,517 | — | $0 | 217,658 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2017-03-20 | 2017-03-21 | 21,517 | $4.47 | $96.2K | 31,306 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2017-03-20 | 2017-03-21 | 11,517 | $20.00 | $230.3K | 9,789 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2017-03-20 | 2017-03-21 | 10,000 | $19.60 | $196.0K | 21,306 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2017-03-09 | 2017-03-09 | 2,500 | — | $0 | 239,175 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2017-03-09 | 2017-03-09 | 2,500 | $4.47 | $11.2K | 9,789 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2017-01-25 | 2017-01-27 | 84,000 | — | $0 | 84,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2016-11-30 | 2016-12-01 | 1,289 | $9.10 | $11.7K | 7,289 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2016-09-29 | 2016-10-03 | 4,000 | — | $0 | 241,675 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2016-09-29 | 2016-10-03 | 4,000 | $4.47 | $17.9K | 6,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise deriv | 2016-05-12 | 2016-05-13 | 2,000 | — | $0 | 245,675 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | M Exercise | 2016-05-12 | 2016-05-13 | 2,000 | $4.47 | $8.9K | 2,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2016-01-21 | 2016-01-25 | 80,000 | — | $0 | 80,000 | SEC↗ |